These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9099602)

  • 21. Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.
    Urabe H; Terashima T; Kojima H; Chan L
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E269-75. PubMed ID: 26695138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.
    Cellek S; Qu W; Schmidt AM; Moncada S
    Diabetologia; 2004 Feb; 47(2):331-9. PubMed ID: 14676945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of cardiac transient outward potassium current by norepinephrine in diabetic rats.
    Gallego M; Casis E; Izquierdo MJ; Casis O
    Pflugers Arch; 2000 Nov; 441(1):102-7. PubMed ID: 11205047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
    Yue DK; Brooks B
    Med J Aust; 1993 Jul; 159(2):76-8. PubMed ID: 8336605
    [No Abstract]   [Full Text] [Related]  

  • 25. Animal models of painful diabetic neuropathy: the STZ rat model.
    Morrow TJ
    Curr Protoc Neurosci; 2004 Nov; Chapter 9():Unit 9.18. PubMed ID: 18428614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats.
    Yu ZY; Geng J; Li ZQ; Sun YB; Wang SL; Masters J; Wang DX; Guo XY; Li M; Ma D
    Br J Anaesth; 2019 Jan; 122(1):141-149. PubMed ID: 30579393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy.
    Kishi M; Tanabe J; Schmelzer JD; Low PA
    Diabetes; 2002 Mar; 51(3):819-24. PubMed ID: 11872686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence.
    Kumar A; Negi G; Sharma SS
    Diabetes Obes Metab; 2011 Aug; 13(8):750-8. PubMed ID: 21447040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The adjuvant effect of hypertension upon diabetic peripheral neuropathy in experimental type 2 diabetes.
    De Visser A; Hemming A; Yang C; Zaver S; Dhaliwal R; Jawed Z; Toth C
    Neurobiol Dis; 2014 Feb; 62():18-30. PubMed ID: 23938761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.
    Tuck RR; Schmelzer JD; Low PA
    Brain; 1984 Sep; 107 ( Pt 3)():935-50. PubMed ID: 6478183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of interleukin-6 treatment on neurovascular function, nerve perfusion and vascular endothelium in diabetic rats.
    Cotter MA; Gibson TM; Nangle MR; Cameron NE
    Diabetes Obes Metab; 2010 Aug; 12(8):689-99. PubMed ID: 20590746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
    Hoybergs YM; Meert TF
    Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequently asked questions about diabetic peripheral neuropathies.
    Harati Y
    Neurol Clin; 1992 Aug; 10(3):783-807. PubMed ID: 1323753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoneurial fluid pressure in experimental models of diabetic neuropathy.
    Powell HC; Costello ML; Myers RR
    J Neuropathol Exp Neurol; 1981 Nov; 40(6):613-24. PubMed ID: 7299419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and related neurotrophic factors in diabetic neuropathy.
    Ishii DN
    Diabet Med; 1993; 10 Suppl 2():14S-15S. PubMed ID: 8334835
    [No Abstract]   [Full Text] [Related]  

  • 36. The axonopathy of diabetic neuropathy.
    Sidenius P
    Diabetes; 1982 Apr; 31(4 Pt 1):356-63. PubMed ID: 6759251
    [No Abstract]   [Full Text] [Related]  

  • 37. Potential clamp experiments on myelinated nerve fibres from alloxan diabetic rats.
    Brismar T
    Acta Physiol Scand; 1979 Mar; 105(3):384-6. PubMed ID: 443069
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.
    Attia HN; Al-Rasheed NM; Al-Rasheed NM; Maklad YA; Ahmed AA; Kenawy SA
    Behav Pharmacol; 2012 Apr; 23(2):153-61. PubMed ID: 22411174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of cytokine in diabetic neuropathy].
    Yagihashi S; Wada R
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():509-15. PubMed ID: 15999761
    [No Abstract]   [Full Text] [Related]  

  • 40. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
    Toth C; Rong LL; Yang C; Martinez J; Song F; Ramji N; Brussee V; Liu W; Durand J; Nguyen MD; Schmidt AM; Zochodne DW
    Diabetes; 2008 Apr; 57(4):1002-17. PubMed ID: 18039814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.